NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 324 filers reported holding NEOGENOMICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229 | -23.4% | 18,600 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $299 | +2.4% | 18,600 | +10.7% | 0.00% | 0.0% |
| Q1 2023 | $292 | +88.4% | 16,800 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $155 | -99.9% | 16,800 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $145,000 | +5.8% | 16,800 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $137,000 | -32.8% | 16,800 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $204,000 | -71.3% | 16,800 | -19.2% | 0.00% | -66.7% |
| Q4 2021 | $710,000 | -29.2% | 20,800 | 0.0% | 0.00% | -40.0% |
| Q3 2021 | $1,003,000 | +6.7% | 20,800 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $940,000 | -11.4% | 20,800 | -5.5% | 0.01% | -16.7% |
| Q1 2021 | $1,061,000 | -10.4% | 22,000 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $1,184,000 | +45.8% | 22,000 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $812,000 | -40.5% | 22,000 | -50.0% | 0.01% | 0.0% |
| Q2 2020 | $1,364,000 | – | 44,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |